Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/63560
Type
ArticleCopyright
Open access
Collections
- AM - ILMD - Artigos de Periódicos [321]
- ENSP - Artigos de Periódicos [2294]
- IOC - Artigos de Periódicos [12490]
Metadata
Show full item record
COOPERATION FOR MALARIA CONTROL AND ELIMINATION IN THE GUIANA SHIELD
Dorinaldo Barbosa Malafaia - Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Programa Educacional em Vigilância em Saúde nas Fronteiras. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Programa Educacional em Vigilância em Saúde nas Fronteiras. Manaus, AM, Brasil / Chamber of Deputies, National Congress, Brasília, Brasil.
Joseli de Oliveira Ferreira - Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.
Emmanuel Roux - ESPACE-DEV, French National Research Institute for Sustainable Development, University of Montpellier, University of the French West Indies, University of French Guiana, University of Reunion Island, and University of Perpignan Via Domitia, Montpellier, France / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Misto Internacional. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório Misto Internacional. Brasília, DF, Brasil / Instituto de Pesquisa para o Desenvolvimento. Laboratório Misto Internacional. França.
Alice Sanna (French West Indies—French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France); Martha Cecilia Suárez Mutis (Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Doenças Parasitárias. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Misto Internacional. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório Misto Internacional. Brasília, DF, Brasil / Instituto de Pesquisa para o Desenvolvimento. Laboratório Misto Internacional. França.); Yann Lambert (French West Indies—French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France); Luisiane Carvalho (Santé Publique France, Cayenne, French Guiana, France); Hedley Cairo (National Malaria Program, Ministry of Health, Paramaribo, Suriname); Horace Cox (Vector-Borne Diseases Unit, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago); Clara de Bort (Regional Health Agency, Cayenne, French Guiana, France); Margarete Gomes do Socorro Mendonça (Secretariat of Health Surveillance of the State of Amapá, Macapá, Brazil); David A Forero-Peña (Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela / Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolívar, Venezuela); Juan Carlos Gabaldón-Figueira (Barcelona Institute for Global Health, Hospital Clinic, University of Barcelona, Barcelona, Spain); Maria Eugenia Grillet (Laboratory of Biology of Vectors and Parasites, Institute of Zoology and Tropical Ecology, Faculty of Sciences, Central University of Venezuela, Caracas, Venezuela); François Klein (Directorate General for Health, Ministry of Health and Prevention, Paris, France); Clément Lazarus (Directorate General for Health, Ministry of Health and Prevention, Paris, France); Yassamine Lazrek (Laboratory of Parasitology, Pasteur Institute in French Guiana, Cayenne, French Guiana, France); Jaime Louzada (Department of Nursing Science, Federal University of Roraima, Boa Vista, Brazil); Dorinaldo Barbosa Malafaia (Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Programa Educacional em Vigilância em Saúde nas Fronteiras. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Programa Educacional em Vigilância em Saúde nas Fronteiras. Manaus, AM, Brasil / Chamber of Deputies, National Congress, Brasília, Brasil); Paola Barbosa Marchesini (Overall Coordination of Surveillance of Zoonoses and Vector-Borne Diseases, Ministry of Health of Brazil, Brasília, Brazil); Lise Musset (Laboratory of Parasitology, Pasteur Institute in French Guiana, Cayenne, French Guiana, France); Joseli de Oliveira Ferreira (Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil); Cássio Roberto Leonel Peterka (Coordination of Malaria Elimination, Ministry of Health of Brazil, Brasília, Brazil); Cyril Rousseau (Division of Decentralized Primary Care Centers, Cayenne Hospital, Cayenne, French Guiana, France); Emmanuel Roux (ESPACE-DEV, French National Research Institute for Sustainable Development, University of Montpellier, University of the French West Indies, University of French Guiana, University of Reunion Island, and University of Perpignan Via Domitia, Montpellier, France / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Misto Internacional. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório Misto Internacional. Brasília, DF, Brasil / Instituto de Pesquisa para o Desenvolvimento. Laboratório Misto Internacional. França); Leopoldo Villegas (Asociación Civil Impacto Social, Tumeremo, Venezuela); Stephen Vreden (Foundation for the Advancement of Scientific Research in Suriname, Paramaribo, Suriname); Solène Wiedner-Papin (Regional Health Agency, Cayenne, French Guiana, France); Gabriel Zorello Laporta (Faculty of Medicine of ABC, Federal University of ABC, Santo André, Brazil); Helene Hiwat (National Malaria Program, Ministry of Health, Paramaribo, Suriname); Maylis Douine (French West Indies—French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France).
Author
Sanna, Alice
Suárez Mutis, Martha Cecilia
Lambert, Yann
Carvalho, Luisiane
Cairo, Hedley
Cox, Horace
Bort, Clara de
Mendonça, Margarete Gomes do Socorro
Forero-Peña, David A.
Gabaldón-Figueira, Juan Carlos
Grillet, Maria Eugenia
Klein, François
Lazarus, Clément
Lazrek, Yassamine
Louzada, Jaime
Malafaia, Dorinaldo Barbosa
Marchesini, Paola Barbosa
Musset, Lise
Ferreira, Joseli de Oliveira
Peterka, Cássio Roberto Leonel
Rousseau, Cyril
Roux, Emmanuel
Villegas, Leopoldo
Vreden, Stephen
Wiedner-Papin, Solène
Laporta, Gabriel Zorello
Hiwat, Helene
Douine, Maylis
Suárez Mutis, Martha Cecilia
Lambert, Yann
Carvalho, Luisiane
Cairo, Hedley
Cox, Horace
Bort, Clara de
Mendonça, Margarete Gomes do Socorro
Forero-Peña, David A.
Gabaldón-Figueira, Juan Carlos
Grillet, Maria Eugenia
Klein, François
Lazarus, Clément
Lazrek, Yassamine
Louzada, Jaime
Malafaia, Dorinaldo Barbosa
Marchesini, Paola Barbosa
Musset, Lise
Ferreira, Joseli de Oliveira
Peterka, Cássio Roberto Leonel
Rousseau, Cyril
Roux, Emmanuel
Villegas, Leopoldo
Vreden, Stephen
Wiedner-Papin, Solène
Laporta, Gabriel Zorello
Hiwat, Helene
Douine, Maylis
Affilliation
Múltipla - ver em Notas
Abstract
The Guiana Shield, a small region of South America, is currently one of the main hotspots of malaria transmission on the continent. This Amazonian area is characterised by remarkable socioeconomic, cultural, health, and political heterogeneity and a high degree of regional and cross-border population mobility, which has contributed to the increase of malaria in the region in the past few years. In this context, regional cooperation to control malaria represents both a challenge and an indispensable initiative. This Viewpoint advocates for the creation of a regional cooperative mechanism for the elimination of malaria in the Guiana Shield. This strategy would help address operational and political obstacles to successful technical cooperation in the region and could contribute to reversing the regional upsurge in malaria incidence through creating a functional international control and elimination partnership.
Publisher
Elsevier
Citation
SANNA, Alice et al. Cooperation for malaria control and elimination in the Guiana Shield. The Lancet Global Health, v. 12, n. 5, p. E875-E881, May 2024.DOI
10.1016/S2214-109X(24)00047-0ISSN
2214-109XNotes
Martha Cecilia Suárez Mutis - Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Doenças Parasitárias. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Misto Internacional. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório Misto Internacional. Brasília, DF, Brasil / Instituto de Pesquisa para o Desenvolvimento. Laboratório Misto Internacional. França.Dorinaldo Barbosa Malafaia - Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Programa Educacional em Vigilância em Saúde nas Fronteiras. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Programa Educacional em Vigilância em Saúde nas Fronteiras. Manaus, AM, Brasil / Chamber of Deputies, National Congress, Brasília, Brasil.
Joseli de Oliveira Ferreira - Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil.
Emmanuel Roux - ESPACE-DEV, French National Research Institute for Sustainable Development, University of Montpellier, University of the French West Indies, University of French Guiana, University of Reunion Island, and University of Perpignan Via Domitia, Montpellier, France / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Misto Internacional. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório Misto Internacional. Brasília, DF, Brasil / Instituto de Pesquisa para o Desenvolvimento. Laboratório Misto Internacional. França.
Alice Sanna (French West Indies—French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France); Martha Cecilia Suárez Mutis (Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Doenças Parasitárias. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Misto Internacional. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório Misto Internacional. Brasília, DF, Brasil / Instituto de Pesquisa para o Desenvolvimento. Laboratório Misto Internacional. França.); Yann Lambert (French West Indies—French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France); Luisiane Carvalho (Santé Publique France, Cayenne, French Guiana, France); Hedley Cairo (National Malaria Program, Ministry of Health, Paramaribo, Suriname); Horace Cox (Vector-Borne Diseases Unit, Caribbean Public Health Agency, Port of Spain, Trinidad and Tobago); Clara de Bort (Regional Health Agency, Cayenne, French Guiana, France); Margarete Gomes do Socorro Mendonça (Secretariat of Health Surveillance of the State of Amapá, Macapá, Brazil); David A Forero-Peña (Faculty of Medicine, Central University of Venezuela, Caracas, Venezuela / Biomedical Research and Therapeutic Vaccines Institute, Ciudad Bolívar, Venezuela); Juan Carlos Gabaldón-Figueira (Barcelona Institute for Global Health, Hospital Clinic, University of Barcelona, Barcelona, Spain); Maria Eugenia Grillet (Laboratory of Biology of Vectors and Parasites, Institute of Zoology and Tropical Ecology, Faculty of Sciences, Central University of Venezuela, Caracas, Venezuela); François Klein (Directorate General for Health, Ministry of Health and Prevention, Paris, France); Clément Lazarus (Directorate General for Health, Ministry of Health and Prevention, Paris, France); Yassamine Lazrek (Laboratory of Parasitology, Pasteur Institute in French Guiana, Cayenne, French Guiana, France); Jaime Louzada (Department of Nursing Science, Federal University of Roraima, Boa Vista, Brazil); Dorinaldo Barbosa Malafaia (Fundação Oswaldo Cruz. Escola Nacional de Saúde Pública Sergio Arouca. Programa Educacional em Vigilância em Saúde nas Fronteiras. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Leônidas e Maria Deane. Programa Educacional em Vigilância em Saúde nas Fronteiras. Manaus, AM, Brasil / Chamber of Deputies, National Congress, Brasília, Brasil); Paola Barbosa Marchesini (Overall Coordination of Surveillance of Zoonoses and Vector-Borne Diseases, Ministry of Health of Brazil, Brasília, Brazil); Lise Musset (Laboratory of Parasitology, Pasteur Institute in French Guiana, Cayenne, French Guiana, France); Joseli de Oliveira Ferreira (Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Imunoparasitologia. Rio de Janeiro, RJ, Brasil); Cássio Roberto Leonel Peterka (Coordination of Malaria Elimination, Ministry of Health of Brazil, Brasília, Brazil); Cyril Rousseau (Division of Decentralized Primary Care Centers, Cayenne Hospital, Cayenne, French Guiana, France); Emmanuel Roux (ESPACE-DEV, French National Research Institute for Sustainable Development, University of Montpellier, University of the French West Indies, University of French Guiana, University of Reunion Island, and University of Perpignan Via Domitia, Montpellier, France / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório Misto Internacional. Rio de Janeiro, RJ, Brasil / Universidade de Brasília. Laboratório Misto Internacional. Brasília, DF, Brasil / Instituto de Pesquisa para o Desenvolvimento. Laboratório Misto Internacional. França); Leopoldo Villegas (Asociación Civil Impacto Social, Tumeremo, Venezuela); Stephen Vreden (Foundation for the Advancement of Scientific Research in Suriname, Paramaribo, Suriname); Solène Wiedner-Papin (Regional Health Agency, Cayenne, French Guiana, France); Gabriel Zorello Laporta (Faculty of Medicine of ABC, Federal University of ABC, Santo André, Brazil); Helene Hiwat (National Malaria Program, Ministry of Health, Paramaribo, Suriname); Maylis Douine (French West Indies—French Guiana Center for Clinical Investigation (CIC Inserm 1424), Department of Research, Innovation, and Public Health, Cayenne Hospital, Cayenne, French Guiana, France).
Share